• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可消化寡糖:呼吸道感染的新疗法?

Non-Digestible Oligosaccharides: A Novel Treatment for Respiratory Infections?

机构信息

Department of Pharmacology, School of Medicine, Southeast University, Nanjing 210009, China.

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3584 CG Utrecht, The Netherlands.

出版信息

Nutrients. 2022 Nov 26;14(23):5033. doi: 10.3390/nu14235033.

DOI:10.3390/nu14235033
PMID:36501062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9736878/
Abstract

Emerging antimicrobial resistance in respiratory infections requires novel intervention strategies. Non-digestible oligosaccharides (NDOs) are a diverse group of carbohydrates with broad protective effects. In addition to promoting the colonization of beneficial gut microbiota and maintaining the intestinal homeostasis, NDOs act as decoy receptors, effectively blocking the attachment of pathogens on host cells. NDOs also function as a bacteriostatic agent, inhibiting the growth of specific pathogenic bacteria. Based on this fact, NDOs potentiate the actions of antimicrobial drugs. Therefore, there is an increasing interest in characterizing the anti-infective properties of NDOs. This focused review provides insights into the mechanisms by which representative NDOs may suppress respiratory infections by targeting pathogens and host cells. We summarized the most interesting mechanisms of NDOs, including maintenance of gut microbiota homeostasis, interference with TLR-mediated signaling, anti-oxidative effects and bacterial toxin neutralization, bacteriostatic and bactericidal effects, and anti-adhesion or anti-invasive properties. A detailed understanding of anti-infective mechanisms of NDOs against respiratory pathogens may contribute to the development of add-on therapy or alternatives to antimicrobials.

摘要

新兴的呼吸道感染抗菌药物耐药性需要新的干预策略。不可消化寡糖(NDOs)是一组具有广泛保护作用的碳水化合物。除了促进有益肠道微生物群的定植和维持肠道内稳态外,NDOs 还可以作为诱饵受体,有效阻止病原体附着在宿主细胞上。NDOs 还具有抑菌作用,抑制特定致病菌的生长。基于这一事实,NDOs 增强了抗菌药物的作用。因此,人们越来越感兴趣的是研究 NDOs 的抗感染特性。本综述重点介绍了代表性 NDOs 通过靶向病原体和宿主细胞来抑制呼吸道感染的作用机制。我们总结了 NDOs 最有趣的作用机制,包括维持肠道微生物群内稳态、干扰 TLR 介导的信号转导、抗氧化作用和细菌毒素中和、抑菌和杀菌作用以及抗黏附和抗侵袭特性。详细了解 NDOs 对呼吸道病原体的抗感染机制可能有助于开发附加治疗或替代抗菌药物的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7faa/9736878/2675ec965f71/nutrients-14-05033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7faa/9736878/2675ec965f71/nutrients-14-05033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7faa/9736878/2675ec965f71/nutrients-14-05033-g001.jpg

相似文献

1
Non-Digestible Oligosaccharides: A Novel Treatment for Respiratory Infections?不可消化寡糖:呼吸道感染的新疗法?
Nutrients. 2022 Nov 26;14(23):5033. doi: 10.3390/nu14235033.
2
Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro.体外不可消化低聚糖的抗病原体功能。
Nutrients. 2020 Jun 16;12(6):1789. doi: 10.3390/nu12061789.
3
Non-Digestible Oligosaccharides and Short Chain Fatty Acids as Therapeutic Targets against Enterotoxin-Producing Bacteria and Their Toxins.不可消化寡糖和短链脂肪酸作为针对产肠毒素细菌及其毒素的治疗靶点
Toxins (Basel). 2021 Feb 25;13(3):175. doi: 10.3390/toxins13030175.
4
Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut.非消化性低聚糖对肠漏的直接作用。
Nutrients. 2022 Nov 7;14(21):4699. doi: 10.3390/nu14214699.
5
Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections.探索人乳寡糖作为抵御病毒感染的防御物。
ACS Infect Dis. 2021 Feb 12;7(2):254-263. doi: 10.1021/acsinfecdis.0c00807. Epub 2021 Jan 20.
6
Beneficial effects of human milk oligosaccharides on gut microbiota.人乳寡糖对肠道微生物群的有益作用。
Benef Microbes. 2014 Sep;5(3):273-83. doi: 10.3920/BM2013.0080.
7
Neuroprotective Potential of Non-Digestible Oligosaccharides: An Overview of Experimental Evidence.不可消化寡糖的神经保护潜力:实验证据综述
Front Pharmacol. 2021 Aug 23;12:712531. doi: 10.3389/fphar.2021.712531. eCollection 2021.
8
Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients.不可消化的低聚糖可抑制花生过敏患者全血中的嗜碱性粒细胞脱颗粒。
Front Immunol. 2018 Jun 11;9:1265. doi: 10.3389/fimmu.2018.01265. eCollection 2018.
9
Effects of Nondigestible Oligosaccharides on Obesity.非消化性寡糖对肥胖的影响。
Annu Rev Food Sci Technol. 2020 Mar 25;11:205-233. doi: 10.1146/annurev-food-032519-051743. Epub 2020 Jan 17.
10
Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota.营养金标准:人乳寡糖及其对婴儿肠道微生物群影响的综述。
Microb Cell Fact. 2021 May 28;20(1):108. doi: 10.1186/s12934-021-01599-y.

引用本文的文献

1
In Vivo Evidence on the Emerging Potential of Non-Digestible Oligosaccharides as Therapeutic Agents in Bacterial and Viral Infections.非消化性寡糖作为细菌和病毒感染治疗剂的新兴潜力的体内证据。
Nutrients. 2025 Mar 19;17(6):1068. doi: 10.3390/nu17061068.

本文引用的文献

1
Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro.半乳糖寡糖通过抑制 NLRP3 炎性小体的激活来减轻肺部炎症,无论是在体内还是体外研究中。
J Adv Res. 2022 Jul;39:305-318. doi: 10.1016/j.jare.2021.10.013. Epub 2021 Nov 1.
2
Galacto-oligosaccharides as an anti-bacterial and anti-invasive agent in lung infections.半乳糖寡糖作为肺部感染的一种抗细菌和抗侵袭剂。
Biomaterials. 2022 Apr;283:121461. doi: 10.1016/j.biomaterials.2022.121461. Epub 2022 Mar 5.
3
Dietary Fibers: Effects, Underlying Mechanisms and Possible Role in Allergic Asthma Management.
膳食纤维:作用、潜在机制及其在过敏性哮喘管理中的可能作用。
Nutrients. 2021 Nov 19;13(11):4153. doi: 10.3390/nu13114153.
4
Anti-Inflammatory Properties of Fructo-Oligosaccharides in a Calf Lung Infection Model and in -Infected Airway Epithelial Cells.低聚果糖在牛肺部感染模型和感染的气道上皮细胞中的抗炎特性。
Nutrients. 2021 Oct 6;13(10):3514. doi: 10.3390/nu13103514.
5
Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.短链脂肪酸作为一种感染治疗的潜在方法:肺部的深入观察。
Infect Immun. 2021 Aug 16;89(9):e0018821. doi: 10.1128/IAI.00188-21.
6
Non-Digestible Oligosaccharides and Short Chain Fatty Acids as Therapeutic Targets against Enterotoxin-Producing Bacteria and Their Toxins.不可消化寡糖和短链脂肪酸作为针对产肠毒素细菌及其毒素的治疗靶点
Toxins (Basel). 2021 Feb 25;13(3):175. doi: 10.3390/toxins13030175.
7
Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections.探索人乳寡糖作为抵御病毒感染的防御物。
ACS Infect Dis. 2021 Feb 12;7(2):254-263. doi: 10.1021/acsinfecdis.0c00807. Epub 2021 Jan 20.
8
Mannheimia haemolytica and lipopolysaccharide induce airway epithelial inflammatory responses in an extensively developed ex vivo calf model.溶血曼海姆菌和脂多糖诱导体外培养的小牛气道上皮细胞产生炎症反应。
Sci Rep. 2020 Aug 3;10(1):13042. doi: 10.1038/s41598-020-69982-0.
9
Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro.体外不可消化低聚糖的抗病原体功能。
Nutrients. 2020 Jun 16;12(6):1789. doi: 10.3390/nu12061789.
10
Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases.人乳寡糖的免疫调节作用:预防过敏性疾病的潜在作用。
Front Immunol. 2020 May 7;11:801. doi: 10.3389/fimmu.2020.00801. eCollection 2020.